Albania Confirms HIV Infected Cases Through Transfusion
Posted on: Saturday, 1 October 2005, 09:00 CDT
Albania confirms HIV infected cases through transfusion
TIRANA, Sept. 30 (Xinhua) -- Albanian ministry of health announced Friday that there had been four cases infected with HIV virus and several others with hepatitis C and B among the poly- transfused patients of thalassemia in the country
. The commission of specialists, who were ordered to review the situation and functioning of the country's blood collection and control system, ascertained that 2.1 percent of the patients had been infected, the Minister of Health Maksim Cikuli was quoted by the Albanian Telegraph Agency (ATA) as saying. "We are not dealing with an extraordinary situation, but the commission has observed that the blood donation practice has some defects, mainly on the functioning of the National Blood Committee, " Cikuli said. According to the ATA, there are around 500 patients of thalassemia in Albania, most of whom need frequent blood transfusion, while the state blood reservation is insufficient at present.Source: Xinhua News Agency - CEIS
Related Articles
- Zero Patient Infections Reported As D.I.S.C. Spine and Sports Center Sets New Standard for Specialty Hospitals
- 960-Patient Study Demonstrates Zero Blood Stream Infection In Patients Treated With Angiotech's Novel 5-FU Central Venous Catheter
- European Committee Issues Positive Opinion of Pfizer's Celsentri(R) (Maraviroc) for Treatment-Experienced Patients Infected With CCR5-Tropic HIV-1
- Pfizer Receives Positive Opinion From CHMP for Celsentri(R) (Maraviroc) for Treatment-Experienced Patients Infected With CCR5-Tropic HIV-1
- FDA Advisory Committee Recommends Accelerated Approval of Pfizer's Maraviroc for Treatment-Experienced Patients Infected With CCR5-Tropic HIV-1
- AdvanDx Releases Data From IDSA Abstract: Impact of Peptide Nucleic Acid (PNA) Fluorescence in Situ Hybridization (FISH) for Enterococcal Blood Stream Infections
- The New England Journal of Medicine Publishes Results of Cubist's Landmark Study of Staphylococcus Aureus Blood Stream Infections; Study Results Led to Recent Label Expansion for CUBICIN
- Blood-Borne Infectivity Study Completed: Results Show Dramatic Reduction in TSE Prions Using PRDT Technology
- Pounds 750,000 Award for Infected Blood Patient
- Hospital Patients Infected
User Comments (0)

RSS Feeds